KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Dividends Paid - Common (2018)

Biolife Solutions (BLFS) reported Dividends Paid - Common of $130000.0 for Q4 2018, up 39.78% on a QoQ basis from $93000.0 in Q3 2018.

Biolife Solutions (BLFS) has 1 years of Dividends Paid - Common data on file, last reported at $130000.0 in Q4 2018.

  • Quarterly Dividends Paid - Common changed N/A year-over-year to $130000.0 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $436000.0 (changed N/A YoY) and the FY2018 annual result came in at $436000.0, up 311.32% from the prior year.
  • Dividends Paid - Common improved to $130000.0 in Q4 2018 per BLFS's latest filing, from $93000.0 in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $130000.0 in Q4 2018 and bottomed at $93000.0 in Q3 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 290.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 87.24 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 15.80 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 5.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 30.92 Mn
10 Biolife Solutions 1.20 Bn 1.12 Bn 17.50 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2018 130,000.00
Dec 31, 2018 130,000.00
Sep 30, 2018 93,000.00
Sep 30, 2018 93,000.00
Jun 30, 2018 107,000.00
Jun 30, 2018 107,000.00
Mar 30, 2018 106,000.00
Mar 30, 2018 106,000.00